A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy
Clinical trial NCT03320031 · UNKNOWN
Trial details
- NCT number
- NCT03320031
- Sponsor
- Yanbing Li
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-03
- Primary completion
- 2019-12-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.